← Open Payments lookup

PAMELA GARZA: Open Payments

NPI 1841232758 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$811 in 30 payments from 15 companies in 2025. Trend: 2023 $333 · 2024 $344 · 2025 $811

Food & beverage: $811
CompanyPaymentsAmount
Janssen Biotech, Inc.6$182
E.R. Squibb & Sons, L.L.C.1$120
Daiichi Sankyo Inc.4$77
AstraZeneca Pharmaceuticals LP3$61
Genmab U.S., Inc.2$58
Celgene Corporation3$55
KYOWA KIRIN, INC.2$50
GlaxoSmithKline, LLC.2$43
Regeneron Healthcare Solutions, Inc.1$34
Gilead Sciences, Inc.1$31

Products named: RYBREVANT, BREYANZI, LYNPARZA, Enhertu, Epkinly, REBLOZYL, POTELIGEO, TECVAYLI.

Industry payments across TX — which companies pay providers there.